Preparation of IFN-γ-containing liposomes for colon cancer treatment. Sustained release in vitro for 144 h with an abrupt onset and increased cytokine-activated antitumor immune response in BALB/c mice with C-26 tumor cells. The gene discussed is IFNG; the disease is malignant colon neoplasm.